[Tumor suppressive effect].
Takai
Shinji
S
Department of Pharmacology, Osaka Medical College.
Miyazaki
Mizuo
M
D000804:Angiotensin II / Q000037:antagonists & inhibitors / Q000502:physiology; D047228:Angiotensin II Type 1 Receptor Blockers / Q000494:pharmacology / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D053818:Chymases; D006801:Humans; D009369:Neoplasms / Q000098:blood supply* / Q000188:drug therapy* / Q000209:etiology; D009389:Neovascularization, Pathologic / Q000188:drug therapy; D012697:Serine Endopeptidases / Q000502:physiology
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D000804:Angiotensin II; D012697:Serine Endopeptidases; D053818:Chymases